Division of Adolescent Medicine, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 4000, Cincinnati, OH 45229, USA; University of Cincinnati College of Medicine, 3235 Eden Avenue, CARE/Crawley Building Suite E-870, Cincinnati, OH 45267, USA.
Vaccine. 2013 Oct 1;31(42):4894-901. doi: 10.1016/j.vaccine.2013.07.033. Epub 2013 Aug 3.
Because little is known about the content of human papillomavirus (HPV) vaccine-related discussions with young adolescent girls in clinical settings, we explored communication between 11- and 12 year-old girls, mothers, and clinicians regarding HPV vaccines and concordance in reports of maternal and clinician communication.
We conducted individual interviews with 33 girls who had received the quadrivalent HPV vaccine in urban and suburban clinical settings, their mothers, and their clinicians. Data were analyzed using qualitative methods.
From the perspectives of both girls and mothers, clinicians and parents were the preferred sources of HPV vaccine information for girls. Vaccine efficacy and risks/benefits of vaccination were the most commonly reported desired and actual topics of discussion by mothers, girls, and clinicians. Clinician recommendation of vaccination was reported by nearly one-fifth of girls and nearly half of mothers. The most common concordant messages were related to efficacy of the vaccine, with concordance in 70% of triads. The most common discordant messages were related to sexual health. Approximately half of clinicians (16) reported discussing sexual health, but only 5 mothers (15%) and 4 girls (12%) reported this. Triads recruited from suburban (vs. urban) practices had higher degrees of concordance in reported vaccination communication.
HPV vaccine efficacy and safety are important topics for clinicians to discuss with both girls and mothers; educating mothers is important because parents are a preferred source of vaccine-related information for girls. Because girls may be missing important vaccine-related messages, they should be encouraged to actively engage in vaccine discussions.
由于人们对临床环境中 11-12 岁少女与人乳头瘤病毒（HPV）疫苗相关讨论的内容知之甚少，我们探讨了 11-12 岁女孩、母亲和临床医生之间关于 HPV 疫苗的沟通情况，以及母亲和临床医生报告的沟通情况是否一致。
我们对 33 名在城市和郊区临床环境中接受四价 HPV 疫苗接种的女孩、她们的母亲及其临床医生进行了单独访谈。使用定性方法分析数据。
从女孩和母亲的角度来看，临床医生和父母是女孩 HPV 疫苗信息的首选来源。疫苗功效和接种风险/获益是母亲、女孩和临床医生最常报告的讨论主题。近五分之一的女孩和近一半的母亲报告说临床医生推荐接种疫苗。报告的最常见一致信息与疫苗的功效有关，三分之二的信息是一致的。最常见的不一致信息与性健康有关。大约一半的临床医生（16 人）报告讨论了性健康问题，但只有 5 位母亲（15%）和 4 位女孩（12%）报告了这一点。从郊区（而非城市）诊所招募的三胞胎在报告的疫苗接种沟通方面一致性更高。
HPV 疫苗的功效和安全性是临床医生与女孩及其母亲讨论的重要话题；对母亲进行教育很重要，因为父母是女孩疫苗相关信息的首选来源。由于女孩可能会错过重要的疫苗相关信息，因此应鼓励她们积极参与疫苗讨论。
